Probiotics Improve Urogenital Health in Women

Andrea Ballini, Luigi Santacroce, Stefania Cantore, Lucrezia Bottalico, Gianna Dipalma, Danila De Vito, Rajiv Saini, Francesco Inchingolo, Andrea Ballini, Luigi Santacroce, Stefania Cantore, Lucrezia Bottalico, Gianna Dipalma, Danila De Vito, Rajiv Saini, Francesco Inchingolo

Abstract

Background: Urogenital recurrent infections represent a global medical issue in the world, affecting millions of women because of dramatic shifts in bacterial composition and concentrations in response to numerous endogenous and exogenous factors. Urogenital microbiota forms a mutually beneficial relationship with their host and has a major impact on health and disease.

Aim: This study aimed to compare probiotic therapy versus placebo in Oxidative Stress Values (OSVs) and histological features in urogenital infections in female patients.

Methods: Forty (n = 40) patients diagnosed with recurrent urogenital infections were recruited to be treated as test group (n = 20), receiving Probiotics, and a control group (n = 20), receiving looking similar placebo, both for 90 days. Both the groups were assessed for total oxidant capacity (d-ROMs test) and biological antioxidant potential as iron-reducing activity (BAP test) at baseline, after 1 and 3 months. Histological changes on inner vaginal mucosa were also investigated, during the entire study.

Results: d-ROM assay clearly showed that the values of the test group were significantly different, thus leading the general health conditions from a state of high oxidative stress to low oxidative stress levels. Increasing of BAP values were more significant, and clinically relevant, in probiotic test group over time.

Conclusion: Our pilot study gave interesting and promising elements to confirm the safety and effectiveness of oral probiotics in preventing/reducing the recurrent urogenital infections by an overall modification of inner vaginal microbiota.

Keywords: Nutraceutics; Probiotics; Urogenital Tract Infections; Vaginal infections; Vaginal microbiota.

Figures

Figure 1
Figure 1
Patient recruitment and selection
Figure 2
Figure 2
Comparative chart: bap-assay
Figure 3
Figure 3
Comparative chart: d-ROM-Assay

References

    1. Skerk V, Markotić A. Urogenital infections--antimicrobial treatment. Med Glas (Zenica) 2010;7(1):1–11.
    1. Reid G, Bruce AW. Urogenital infections in women: can probiotics help? Postgrad Med J. 2003;79(934):428–432. PMid:12954951 PMCid: PMC1742800.
    1. Foxman B, Barlow R, D'Arcy H, et al. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol. 2000;10:509–15. .
    1. Cicinelli E, Ballini A, Marinaccio M, Poliseno A, Coscia MF, Monno R, De Vito D. Microbiological findings in endometrial specimen: our experience. Arch Gynecol Obstet. 2012;285(5):1325–9. PMid:22113463.
    1. Perrotta C, Aznar M, Mejia R, Albert X, Ng CW. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev. 2008;16(2):CD005131. .
    1. Giudice G, Cutrignelli DA, Sportelli P, Limongelli L, Tempesta A, Gioia GD, Santacroce L, Maiorano E, Favia G. Rhinocerebral Mucormycosis with Orosinusal Involvement: Diagnostic and Surgical Treatment Guidelines. Endocr Metab Immune Disord Drug Targets. 2016;16(4):264–269. PMid:28017141.
    1. John AS, Mboto CI, Agbo B. A review of the prevalence and predisposing factors responsible for urinary tract infection among adults. Euro J Exp Bio. 2016;6(4):7–11.
    1. Hanson L, VandeVusse L, Jermé M, Abad CL, Safdarv N. Probiotics for Treatment and Prevention of Urogenital Infections in Women: A Systematic Review. J Midwifery Womens Health. 2016;61(3):339–55. PMid: 27218592.
    1. Marrelli M, Tatullo M, Dipalma G, Inchingolo F. Oral infection by Staphylococcus aureus in patients affected by White Sponge Nevus: a description of two cases occurred in the same family. Int J Med Sci. 2012;9(1):47–50. PMid:22211089.
    1. Reid G, Beuerman D, Heinemann C, Bruce AW. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbiol. 2001;32(1):37–41. PMid:11750220.
    1. Reid G, Bruce AW. Selection of Lactobacillus strains for urogenital probiotic applications. J Infect Dis. 2001;1(183):S77–S80. PMid:11171021.
    1. Reid G, Bruce AW, Taylor M. Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clin Ther. 1992;14(1):11–6. PMid:1576619.
    1. Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B. Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol. 2001;30(1):49–52. PMid:11172991.
    1. Tatullo M, Marrelli M, Scacco S, Lorusso M, Doria S, Sabatini R, Auteri P, Cagiano R, Inchingolo F. Relationship between oxidative stress and “burning mouth syndrome” in female patients: a scientific hypothesis. Eur Rev Med Pharmacol Sci. 2012;16(9):1218–21. PMid:23047505.
    1. Ballini A, Santacroce L, Cantore S, Bottalico L, Dipalma G, De Vito D, Gargiulo C, Saini R, Inchingolo F. Probiotics Efficacy on Oxidative Stress Values in Inflammatory Bowel Disease: A Randomized Double-Blinded Placebo-Controlled Pilot Study. Endocr Metab Immune Disord Drug Targets. 2018 (in press) PMid:29692270.
    1. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardization method of Gram stain interpretation. J Clin Microbiol. 1991;29(2):297–301. PMid:1706728 PMCid: PMC269757.
    1. Tatullo M, Simone GM, Tarullo F, Irlandese G, Vito D, Marrelli M, Santacroce L, Cocco T, Ballini A, Scacco S. Antioxidant and Antitumor Activity of a Bioactive Polyphenolic Fraction Isolated from the Brewing Process. Sci Rep. 2016;27(6):36042. PMid:27786308 PMCid: PMC5081531.
    1. Belge Kurutas E, Ciragil P, Gul M, Kilinc M. The Effects of Oxidative Stress in Urinary Tract Infection. Mediators Inflamm. 2005;2005(4):242–244. PMid:16192676 PMCid: PMC1526480.
    1. Ballini A, Cantore S, Fatone L, Montenegro V, De Vito D, Pettini F, Crincoli V, Antelmi A, Romita P, Rapone B, Miniello G, Perillo L, Grassi FR, Foti C. Transmission of non-viral sexually transmitted infections and oral sex. J Sex Med. 2012;9(2):372–84. PMid:22023797.
    1. Raz R. Hormone replacement therapy or prophylaxis in postmenopausal women with recurrent urinary tract infection. J Infect Dis. 2001;183(1):S74–6. PMid:11171020.
    1. Anukam KC, Osazuwa E, Osemene GI, Ehigiagbe F, Bruce AW, Reid G. Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect. 2006;8(12-13):2772–2776. PMid:17045832.
    1. Pascual L, Ruiz F, Giordano W, Barberis I. Vaginal colonization and activity of the probiotic bacterium Lactobacillus fermentum L23 in a murine model of vaginal tract infection. J Med Microbiol. 2009;59(3):360–364. PMid:19926731.
    1. Atassi F, Brassart D, Grob P, Graf F, Servin AL. Lactobacillus strains isolated from the vaginal microbiota of healthy women inhibit Prevotella bivia and Gardnerella vaginalis in coculture and cell culture. FEMS Immunol Med Microbiol. 2006;48(3):424–432. PMid:17059467.
    1. Gil NF, Martinez RC, Gomes BC, Nomizo A, De Martinis EC. Vaginal lactobacilli as potential probiotics against Candida spp. Braz J Microbiol. 2010;41(1):6–14. PMid:24031455 PMCid: PMC3768620.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel